- Home
- FSV vs LEGN Comparison
FSV vs LEGN Comparison
Compare FSV & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FSV | LEGN |
|---|---|---|
| Founded | 1988 | 2014 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 5.9B |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FSV | LEGN |
|---|---|---|
| Price | $154.92 | $19.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 14 |
| Target Price | ★ $210.67 | $63.46 |
| AVG Volume (30 Days) | 269.9K | ★ 2.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 0.73% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.43 | $67.72 |
| Revenue Next Year | $6.65 | $43.82 |
| P/E Ratio | $49.49 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $147.23 | $16.24 |
| 52 Week High | $205.99 | $45.30 |
Technical Indicators
Market Signals| Indicator | FSV | LEGN |
|---|---|---|
| Relative Strength Index (RSI) | 50.79 | 54.68 |
| Support Level | $149.03 | $16.24 |
| Resistance Level | $158.41 | $23.68 |
| Average True Range (ATR) | 4.46 | 0.86 |
| MACD | -0.17 | 0.45 |
| Stochastic Oscillator | 50.23 | 60.61 |
Price Performance
Historical ComparisonAbout FSV FirstService Corporation
FirstService Corp operates in two business divisions: FirstService Residential and FirstService Brands. FirstService Residential has service contracts to manage thousands of residential communities, including high-, medium-, and low-rise condominiums and co-operatives. FirstService Brands generates the majority of the company's revenue and provides property services to residential and commercial customers through the following brands: California Closets; Paul Davis Restoration; CertPro Painters; Pillar to Post; Floor Coverings International; College Pro Painters; and Service America. The company earns the majority of its revenue in the United States, with the remaining revenue generated in Canada.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.